Pfizer Inc (NYSE:PFE), an American multinational Pharmaceutical company headquartered in New York, announced on Thursday that its board of directors has declared a USD0.38 per share fourth-quarter 2020 dividend on the company's common stock.
The dividend is payable 1 December 2020, to holders of the Common Stock of record at the close of business on 6 November 2020.
The fourth-quarter 2020 cash dividend will be the 328th consecutive quarterly dividend paid by Pfizer.
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline